Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

Long-Term Follow-up Safety of Clonidine Micropellets

ClinicalTrials.gov ID: NCT03776318

Public ClinicalTrials.gov record NCT03776318. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 29, 2026, 8:01 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Follow-up Study to Evaluate the Long-Term Safety of Clonidine Micropellets for the Treatment of Pain Associated With Lumbosacral Radiculopathy in Adults

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Long-term follow-up study to evaluate the safety of clonidine micropellets up to 12 months post injection.

Study identification

NCT ID
NCT03776318
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
Sollis Therapeutics, Inc.
Industry
Enrollment
100 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 15, 2018 (Actual)
Primary completion
Jan 22, 2021 (Actual)
Completion
May 31, 2021 (Actual)
Last update posted
Oct 6, 2023

2018 – 2021

United States locations

U.S. sites
25
U.S. states
19
U.S. cities
24
Facility City State ZIP Site status
Sollis Clinical Study Site 36 Mobile Alabama 36605 —
Sollis Clinical Study Site 44 Phoenix Arizona 85053 —
Sollis Clinical Study Site 40 Tucson Arizona 85724 —
Sollis Clinical Study Site 49 Rancho Mirage California 92270 —
Sollis Clinical Study Site 30 Washington D.C. District of Columbia 22205 —
Sollis Clinical Study Site 35 Fort Lauderdale Florida 33316 —
Sollis Clinical Study Site 38 Miami Florida 33135 —
Sollis Clinical Study Site 12 Bloomington Illinois 61704 —
Sollis Clinical Study Site 13 Chicago Illinois 60657 —
Sollis Clinical Study Site 14 Kansas City Kansas 66160 —
Sollis Clinical Study Site 37 Overland Park Kansas 66210 —
Sollis Clinical Study Site 10 Edgewood Kentucky 41017 —
Sollis Clinical Study Site 15 Brookline Massachusetts 02445 —
Sollis Clinical Study Site 17 Shrewsbury New Jersey 07702 —
Sollis Clinical Study Site 31 Rochester New York 14618 —
Sollis Clinical Study Site 18 Winston-Salem North Carolina 27103 —
Sollis Clinical Study Site 21 Cleveland Ohio 44106 —
Sollis Clinical Study Site 33 Cleveland Ohio 44195 —
Sollis Clinical Study Site 19 Edmond Oklahoma 73013 —
Sollis Clinical Study Site 46 Eugene Oregon 97401 —
Sollis Clinical Study Site 42 Dallas Texas 75240 —
Sollis Clinical Study Site 34 Houston Texas 77004 —
Sollis Clinical Study Site 47 Salt Lake City Utah 84107 —
Sollis Clinical Study Site 23 Morgantown West Virginia 26506 —
Sollis Clinical Study Site 27 Madison Wisconsin 53792 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03776318, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 6, 2023 · Synced Oct 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03776318 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →